Chymoral Forte: Primary Indications and Clinical Use
Chymoral Forte (trypsin-chymotrypsin combination) is primarily indicated as an anti-inflammatory and proteolytic enzyme preparation for facilitating tissue repair following acute tissue injury, including surgical wounds, traumatic injuries, burns, and inflammatory conditions.
Primary Clinical Indications
Tissue Repair and Wound Healing
- Chymoral Forte accelerates resolution of inflammatory symptoms and promotes speedier recovery from acute tissue injury through its proteolytic enzyme activity 1
- The combination has been in clinical use since the 1960s for managing various forms of tissue damage including surgical injuries, accidental trauma, fractures, and burns 1
- In burn injury management specifically, trypsin-chymotrypsin demonstrates anti-inflammatory activity by modulating acute-phase protein responses and reducing tissue destruction 2
Anti-Inflammatory Mechanism
- The enzyme preparation exhibits significant anti-inflammatory effects by reducing edema formation and limiting tissue destruction at injury sites 3
- Treatment with trypsin-chymotrypsin reduces C-reactive protein elevation while enhancing protective acute-phase proteins (alpha-1-antitrypsin, alpha-2-macroglobulin) compared to untreated controls 2
- The preparation decreases lipid peroxidation products and maintains higher levels of enzymatic antioxidants (superoxide dismutase, catalase, glutathione peroxidase), contributing to reduced oxidative damage during tissue injury 3
Additional Clinical Applications
Pain Management
- Trypsin-chymotrypsin demonstrates efficacy comparable to NSAIDs (specifically ibuprofen 600mg) for postoperative pain management 4
- The enzyme combination can be used as an alternative analgesic option, though it shows no synergistic benefit when combined with NSAIDs 4
Dental Applications
- The preparation is mentioned in polyherbal dental products alongside papain and bromelain for anti-edematous, anti-inflammatory, anti-thrombotic, and fibrinolytic actions 5
Important Clinical Considerations
Safety Profile
- Occupational exposure to trypsin and chymotrypsin dusts can cause immediate hypersensitivity reactions of the airways with documented cases of specific IgE-mediated sensitization 6
- Immediate urticarial skin reactions are possible upon contact, though allergic delayed-type eczematous reactions lack clear evidence 6
- The clinical safety profile in therapeutic oral use appears acceptable based on randomized controlled trial data 4
Mechanism of Action
- As proteolytic enzymes, trypsin and chymotrypsin facilitate the breakdown of damaged tissue proteins, promoting the natural healing cascade through all four phases: hemostasis, inflammation, proliferation, and remodeling 1
- The enzymes help prevent progression from acute to chronic wounds by supporting effective resolution of the inflammatory phase 1